Oncimmune announces new contract with global pharma company
The contract concerns profiling Immunoglobulin E autoantibodies in blood serum
Read More
Tag: Oncimmune
Oncimmune/Medicines Discovery Catapult win UK government funding for COVID-19 research tool
Research tool will predict disease severity and therapeutic response
Read More
Oncimmune partners with Genentech to profile samples from rheumatology trials
UK-headquartered company will characterise autoantibody profiles of clinical trial patients
Read More
Oncimmune signs commercialisation partnership in Russia
The five-year initial term aims to generate revenues of at least £5 million.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
